GlaxoSmithKline Pakistan Market Cap

GlaxoSmithKline Pakistan has a market cap or net worth of 131.04 billion as of January 29, 2025. Its market cap has increased by 401.17% in one year.

Market Cap

131.04B

Enterprise Value

124.51B

Revenue

56.23B

Ranking

n/a

PE Ratio

29.07

Stock Price

411.46

Market Cap Chart

Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 131.04B, an increase of 3,374.99%. That is a compound annual growth rate of 12.40%.

Market Cap History

Date	Market Cap	% Change
Jan 29, 2025	131.04B	3.67%
Dec 31, 2024	126.40B	378.26%
Dec 29, 2023	26.43B	-5.45%
Dec 30, 2022	27.95B	-35.70%
Dec 31, 2021	43.47B	-28.84%
Dec 31, 2020	61.09B	19.47%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbott Laboratories (Pakistan)	125.47B
The Searle Company	57.21B
AGP Limited	51.90B
Highnoon Laboratories	48.11B
Shifa International Hospitals	26.60B
Citi Pharma	20.93B
Ferozsons Laboratories	14.75B
Otsuka Pakistan	2.43B

Market Cap Rankings